
Amplitude Surgical Shareholders Strike Deal For Sale of 75.4% Interest to Zydus Lifesciences

I'm PortAI, I can summarize articles.
Holders of 75.4% of Amplitude Surgical's shares have agreed to sell their majority stake to Zydus Lifesciences for 6.25 euros per share. Including previous agreements, Zydus will acquire 85.6% of the French orthopedic company. The deal is expected to close in Q3, pending conditions. With additional minority shareholders also agreeing to sell, Zydus anticipates acquiring over 90% and initiating a squeeze-out for remaining shares.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

